Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cario

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Leukemia|May 7, 2011
Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatmentC Eckert, T Flohr, R Koehler, et al.
Leukemia|June 25, 2015
Effects of p38α/β inhibition on acute lymphoblastic leukemia proliferation and survival in vivoA Alsadeq, S Strube, S Krause, et al.
European Journal of Pediatrics|March 26, 2015
Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factorsR A Ammann, H J Laws, D Schrey, et al.
Leukemia|June 9, 2006
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networksF J T Staal, G Cario, G Cazzaniga, et al.
Leukemia|March 10, 2015
Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessmentC Eckert, N Hagedorn, L Sramkova, et al.
Leukemia|December 1, 2016
Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemiaC Vesely, C Frech, C Eckert, et al.
Blood Cancer Journal|February 4, 2017
Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemiaP Richter-Pechańska, J B Kunz, J Hof, et al.
Klinische Padiatrie|May 24, 2013
Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000M Schrappe, A Möricke, A Reiter, et al.
Leukemia|November 26, 2013
CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineageL Slamova, J Starkova, E Fronkova, et al.
Leukemia|April 10, 2012
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemiaC Palmi, E Vendramini, D Silvestri, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Leukemia|May 7, 2011
Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatmentC Eckert, T Flohr, R Koehler, et al.
Leukemia|June 25, 2015
Effects of p38α/β inhibition on acute lymphoblastic leukemia proliferation and survival in vivoA Alsadeq, S Strube, S Krause, et al.
European Journal of Pediatrics|March 26, 2015
Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factorsR A Ammann, H J Laws, D Schrey, et al.
Leukemia|June 9, 2006
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networksF J T Staal, G Cario, G Cazzaniga, et al.
Leukemia|March 10, 2015
Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessmentC Eckert, N Hagedorn, L Sramkova, et al.
Leukemia|December 1, 2016
Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemiaC Vesely, C Frech, C Eckert, et al.
Blood Cancer Journal|February 4, 2017
Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemiaP Richter-Pechańska, J B Kunz, J Hof, et al.
Klinische Padiatrie|May 24, 2013
Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000M Schrappe, A Möricke, A Reiter, et al.
Leukemia|November 26, 2013
CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineageL Slamova, J Starkova, E Fronkova, et al.
Leukemia|April 10, 2012
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemiaC Palmi, E Vendramini, D Silvestri, et al.
Pageof 3